Washington
Cancer clinical trials in Washington
362 cancer studies are recruiting participants at sites in 33 cities across Washington as of November 16, 2026, according to ClinicalTrials.gov.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Every Washington city with a recruiting study
By research area: Lymphoma (95), Lung Cancer (91), Breast Cancer (86), Prostate Cancer (56), Pancreatic Cancer (23), Melanoma (11).
Seattle (284), Spokane (47), Tacoma (47), Edmonds (42), Vancouver (37), Issaquah (30), Kennewick (24), Bellingham (22), Lacey (18), Everett (16), Renton (16), Walla Walla (16), Aberdeen (15), Longview (15), Sedro-Woolley (15), Centralia (14), Olympia (14), Mount Vernon (13), Bellevue (12), Puyallup (12), Silverdale (12), Yakima (12), Kirkland (10), Gig Harbor (5), Spokane Valley (5), Bonney Lake (4), Federal Way (4), Port Townsend (4), Shelton (4), Wenatchee (3), Yelm (3), Bremerton (2), Auburn (1).
The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.
Breast cancer: recently updated in Washington
Basic details from each study's public record (the 12 most recently updated of 362). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Boehringer Ingelheim
- Recruiting in
- Seattle
- Registry record
- NCT06324357 · updated
Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Washington on ClinicalTrials.gov.
Lung cancer: recently updated in Washington
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- IDEAYA Biosciences
- Recruiting in
- Seattle
- Registry record
- NCT07277413 · updated
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Recruiting in
- Seattle
- Registry record
- NCT07513376 · updated
Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Washington on ClinicalTrials.gov.
Prostate cancer: recently updated in Washington
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
- Phase 2
- Ages 18 and older
- Male participants
- Sponsor
- VA Office of Research and Development
- Recruiting in
- Seattle
- Registry record
- NCT04038502 · updated
High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
- Phase 2
- Ages 18 and older
- Male participants
- Sponsor
- VA Office of Research and Development
- Recruiting in
- Seattle
- Registry record
- NCT05011383 · updated
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
- Phase 3
- Ages 18 and older
- Male participants
- Sponsor
- ECOG-ACRIN Cancer Research Group
- Recruiting in
- Aberdeen · Bellingham · Centralia · and 13 more U.S. locations
- Registry record
- NCT04423211 · updated
Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in Washington on ClinicalTrials.gov.
Melanoma: recently updated in Washington
Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
- Phase 3
- Ages 75 and older
- All sexes
- Sponsor
- ECOG-ACRIN Cancer Research Group
- Recruiting in
- Seattle · Silverdale
- Registry record
- NCT07068074 · updated
Source: ClinicalTrials.gov. Data processed . See every melanoma study recruiting in Washington on ClinicalTrials.gov.
Lymphoma: recently updated in Washington
A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph...
- No phase
- Ages 1 to 25
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Recruiting in
- Seattle
- Registry record
- NCT05621291 · updated
Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy
- Phase 3
- Ages 18 to 75
- All sexes
- Sponsor
- Eastern Cooperative Oncology Group
- Recruiting in
- Aberdeen · Bellingham · Centralia · and 12 more U.S. locations
- Registry record
- NCT06724237 · updated
Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Hoffmann-La Roche
- Recruiting in
- Tacoma
- Registry record
- NCT06806033 · updated
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Nurix Therapeutics, Inc.
- Recruiting in
- Seattle
- Registry record
- NCT07221500 · updated
ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Newave Pharmaceutical Inc
- Recruiting in
- Spokane
- Registry record
- NCT07342478 · updated
Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Washington on ClinicalTrials.gov.
Ask about studies in Washington
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
Oncology Research Hub does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections